Luca Malcovati

发表

appreci8: a pipeline for precise variant calling integrating 8 tools

Julian Varghese, Christian Rohde, Martin Dugas, 2018, Bioinform..

A Rule-Based Expert System for Automatic Implementation of Somatic Variant Clinical Interpretation Guidelines

Riccardo Bellazzi, Ivan Limongelli, Luca Malcovati, 2019, AIME.

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Ying Wang, Shannon McWeeney, Christopher C. Porter, 2018 .

A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data

Silvana Quaglini, Riccardo Bellazzi, Luca Malcovati, 2020, J. Biomed. Informatics.

Revised international prognostic scoring system for myelodysplastic syndromes.

Luca Malcovati, Pierre Fenaux, Mario Cazzola, 2012, Blood.

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Luca Malcovati, Mario Cazzola, M. Cazzola, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts

Luca Malcovati, Eva Hellström-Lindberg, Mario Cazzola, 2008, PloS one.

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Peter J Campbell, Michael R Stratton, Luca Malcovati, 2011, Blood.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Wolfgang Kern, Jean Feuillard, Luca Malcovati, 2009, Haematologica.

Hematologic passport for athletes competing in endurance sports: a feasibility study.

Luca Malcovati, Mario Cazzola, M. Cazzola, 2003, Haematologica.

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Bin Tean Teh, Andrew Menzies, Keiran Raine, 2014, eLife.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Benjamin L. Ebert, Michael R. Savona, John M. Bennett, 2019, Nature Medicine.

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Li Wang, Luca Malcovati, Mario Cazzola, 2006, Blood.

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome

Stefano Guidi, Anna Paola Iori, Luca Malcovati, 2013, American journal of hematology.

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.

Ying Wang, Christopher C. Porter, Anna L. Brown, 2019, Blood advances.

Gene expression and risk of leukemic transformation in myelodysplasia.

Satoru Miyano, Yuichi Shiraishi, Kenichi Chiba, 2017, Blood.

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Luca Malcovati, Mario Cazzola, M. Cazzola, 2011, Haematologica.